
Clene Nanomedicine
Biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases.
Market cap
$34.0m
Enterprise value
$45m
Share price
$3.91 CLNN
Authorizing premium user...
Biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases.